NEW YORK (CBS.MW) -- The IPO road for Rigel Pharmaceuticals has definitely been rocky. The company filed its offering in February 2000. Several months later, the IPO was withdrawn. Then the company re ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...
NEW YORK (CBS.MW) -- Shares of Rigel Pharmaceuticals barely budged from their offering price Wednesday as the troubled initial public offering had its debut amid a calmer mood in the stock market. The ...
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it had entered into an exclusive license and supply agreement with Kissei ...
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback